(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Bruton’s tyrosine ...

November 4, 2024Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $0.909, expectations were $0.9. Operator: Thank you for standing by and welcome to Krystal Biotech's Third Quarter ...

Thank you for standing by and welcome to Krystal Biotech's third-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded. I would now like to hand ...

Mr. Shah Coherent Market Insights Pvt. Ltd. +1 206-701-6702 email us here Visit us on social media: Facebook X LinkedIn ...